RxSight (RXST) Research & Development (2020 - 2026)
RxSight (RXST) posted Research & Development of $9.5 million for Q1 2026, up 6.37% on a QoQ basis from $8.9 million in Q4 2025, and down 8.63% year-over-year from $10.4 million in Q1 2025.
RxSight (RXST) Research & Development (2020 - 2026) Analysis & Trends
RxSight's Research & Development history runs 7 years deep, the most recent figure standing at $9.5 million for Q1 2026.
- Quarterly Research & Development fell 8.63% year-over-year to $9.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.7 million (up 2.59% YoY) and the FY2025 annual result came in at $38.5 million, up 12.17% from the prior year.
- Research & Development was $9.5 million for Q1 2026 at RxSight, up from $8.9 million in the prior quarter.
- Across five years, Research & Development topped out at $10.4 million in Q1 2025 and bottomed at $6.2 million in Q2 2022.
- A 5-year average of $8.1 million and a median of $8.0 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2025 — Research & Development gained 29.09% — and 2026, when it dropped 8.63%.
- RxSight's Research & Development stood at $6.7 million in 2022, then rose by 9.88% to $7.3 million in 2023, then climbed by 25.42% to $9.2 million in 2024, then fell by 3.28% to $8.9 million in 2025, then grew by 6.37% to $9.5 million in 2026.
- Business Quant data shows RXST's Research & Development at $9.5 million in Q1 2026, $8.9 million in Q4 2025, and $9.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | 9.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.47 Mn |
| Dec 31, 2025 | 8.91 Mn |
| Sep 30, 2025 | 9.06 Mn |
| Jun 30, 2025 | 10.22 Mn |
| Mar 31, 2025 | 10.37 Mn |
| Dec 31, 2024 | 9.21 Mn |
| Sep 30, 2024 | 8.84 Mn |
| Jun 30, 2024 | 8.29 Mn |
| Mar 31, 2024 | 8.03 Mn |
| Dec 31, 2023 | 7.34 Mn |
| Sep 30, 2023 | 7.10 Mn |
| Jun 30, 2023 | 7.40 Mn |
| Mar 31, 2023 | 7.21 Mn |
| Dec 31, 2022 | 6.68 Mn |
| Sep 30, 2022 | 6.39 Mn |
| Jun 30, 2022 | 6.19 Mn |
| Mar 31, 2022 | 6.72 Mn |
| Dec 31, 2021 | 5.92 Mn |
| Sep 30, 2021 | 5.38 Mn |
| Jun 30, 2021 | 6.56 Mn |